Effect of selective serotonin reuptake inhibitors on requirement for allogeneic red blood cell transfusion following coronary artery bypass surgery

American Journal of Cardiovascular Drugs

Volumn 6, Issue 4, 2006, Pages 243-250

  Andreasen, Jan Jesper ^a   Riis, Anders ^b   Hjortdal, Vibeke Elisabeth ^b   Jørgensen, Jan ^b   Sørensen, Henrik Toft ^a,b,c   Johnsen, Søren Paaske ^a,b  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; AMOXAPINE; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; CLOPIDOGREL; DESIPRAMINE; DIPYRIDAMOLE; DOSULEPIN; DOXEPIN; FLUVOXAMINE; IMIPRAMINE; LOFEPRAMINE; MAPROTILINE; MIANSERIN; MIRTAZAPINE; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; OPIPRAMOL; PAROXETINE; PROTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRIMIPRAMINE; VENLAFAXINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; CHILD; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DATA BASE; DEMOGRAPHY; DRUG USE; ERYTHROCYTE TRANSFUSION; EXTRACORPOREAL CIRCULATION; FEMALE; HOSPITAL ADMISSION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NORADRENALIN UPTAKE; PREOPERATIVE CARE; PRESCRIPTION; PRIORITY JOURNAL; REOPERATION; RISK FACTOR; SCORING SYSTEM; SEROTONIN UPTAKE;

EID: 33747832499     PISSN: 11753277     EISSN: 11753277     Source Type: Journal    
DOI: 10.2165/00129784-200606040-00004     Document Type: Article

References (27)

1. Spiess BD. Transfusion of blood products affects outcome in cardiac surgery. Semin Cardiothorac Vasc Anesth 2004; 8: 267-81
2. Engoren MC, Habib RH, Zacharias A, et al. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg 2002; 74: 1180-6
3. Magovern JA, Sakert T, Benckart DH, et al. A model for predicting transfusion after coronary artery bypass grafting. Ann Thorac Surg 1996; 61: 27-32
4. Serebruany VL, Gurbel PA, O'Connor CM. Platelet inhibition by sertraline and n-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors. Pharmacol Res 2001; 43: 453-61
5. Hergovich N, Aigner M, Eichler H-G, et al. Paroxetine decreases platelet serotonin storage and platelet dysfunction in human beings. Clin Pharmacol Ther 2000; 68: 435-42
6. Dalton SO, Johansen C, Mellemkjær L, et al. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med 2003; 163: 59-64
7. van Walraven V, Mamdani MM, Wells PS, et al. Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. BMJ 2001; 323: 655-8
8. Meijer WEE, Heerdink ER, Nolen WA, et al. Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med 2004; 164: 2367-70
9. Movig KLL, Janssen WHE, de Malefijt J, et al. Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients. Arch Intern Med 2003; 163: 2354-8
10. Ford DE, Mead LA, Chang PP, et al. Depression is a risk factor for coronary artery disease in men. Arch Intern Med 1998; 158: 1422-6
11. Zellweger MJ, Osterwalder RH, Langewitz W, et al. Coronary artery disease and depression. Eur Heart J 2004; 25: 3-9
12. Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 1996; 93: 1976-80
13. Andersen TF, Madsen M, Jørgensen J, et al. The Danish National Hospital Register: a valuable source of data for modern health sciences. Dan Med Bull 1999; 46: 263-8
14. Tatsumi M, Groshan K, Blakely RD, et al. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 1997; 340: 249-58
15. Transfusion Medicin. Quality assurance databases [online]. Available from URL: http://www.dtdb.dk [Accessed 2005 Jul 8]
16. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83
17. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45: 613-9
18. McNutt LA, Wu C, Xue X, et al. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 2003; 157: 940-3
19. Yaryura-Tobias JA, Kirschen H, Ninan P, et al. Fluoxetine and bleeding in obsessive-compulsive disorder [letter]. Am J Psychiatry 1991; 148: 949
20. Ottervanger JP, Stricker BHC, Huls J, et al. Bleeding attributed to intake of paroxetine [letter]. Am J Psychiatry 1994; 151: 781-2
21. Layton D, Clark DW, Pearce GL, et al. Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England. Eur J Clin Pharmacol 2001; 57: 167-76
22. Maurer-Spurej E, Pittendreigh C, Solomons K. The influence of selective serotonin reuptake inhibitors on human platelet serotonin. Thromb Haemost 2004; 91: 119-28
23. Frasure-Smith N, Lespérance F, Talajic M. Depression following myocardial infarction: impact on 6-month survival. JAMA 1993; 270: 1819-25
24. Monster TBM, Johnsen SP, Olsen ML, et al. Antidepressants and risk of first-time hospitalization for myocardial infarction: a population-based case-control study. Am J Med 2004; 117: 732-7
25. Roose SP, Glassman AH. Antidepressant choice in the patient with cardiac disease: lessons from the Cardiac Arrhytmia Suppression Trial (CAST) studies. J Clin Psychiatry 1994; 55 Suppl. A: 83-7
26. Stover EP, Siegel LC, Parks R, et al. Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines a 24-institution study. Anesthesiology 1998; 88: 327-33
27. Kuduvalli M, Oo AY, Newall N, et al. Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery. Eur J Cardiothorac Surg 2005; 27: 592-8